Multaq and Prinivil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Multaq (dronedarone hydrochloride) and Prinivil (lisinopril). Common drug interactions include acute pulmonary oedema among females and coagulopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Multaq and Prinivil. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Multaq?

Multaq has active ingredients of dronedarone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 11,053 Multaq users. Check the latest studies of Multaq.

What is Prinivil?

Prinivil has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 20,152 Prinivil users. Check the latest studies of Prinivil.

On Jul, 07, 2026

22 people who take Multaq and Prinivil together, and have interactions are studied.

What are the common drug interactions of Multaq and Prinivil, by gender? *:

female:

Acute pulmonary oedema (sudden deposit of fluid in the lung))
Brain natriuretic peptide increased
Cardiac failure congestive
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Death
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Hallucination (an experience involving the perception of something not present)
Hypoxia (low oxygen in tissues)
Leukocytosis (increased white blood cells)

male:

Coagulopathy (blood's ability to clot is impaired)
Haematuria (presence of blood in urine)
Pain in extremity
Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
Peripheral swelling
Thrombosis (formation of a blood clot inside a blood vessel)
Abdominal discomfort
Asthenia (weakness)
Atrial thrombosis (blood clot that develops in an artery)
Brain natriuretic peptide increased

What are the common drug interactions of Multaq and Prinivil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Atrial thrombosis (blood clot that develops in an artery)
Brain natriuretic peptide increased
Cardiac failure congestive
Dyspepsia (indigestion)
Ejection fraction decreased (systolic heart failure)
Hepatitis (inflammation of the liver)
Hepatocellular injury (liver injury)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Hypotension (abnormally low blood pressure)
Ocular icterus (presence of jaundice seen in the sclera of the eye)

30-39:

n/a

40-49:

n/a

50-59:

Death

60+:

Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Coagulopathy (blood's ability to clot is impaired)
Pain in extremity
Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
Peripheral swelling
Thrombosis (formation of a blood clot inside a blood vessel)
Abdominal discomfort
Acute pulmonary oedema (sudden deposit of fluid in the lung))
Asthenia (weakness)
Brain natriuretic peptide increased

What are the existing conditions these people have? *

Chest Pain: 4 people, 18.18%
Sleep Disorder: 3 people, 13.64%
Pain: 3 people, 13.64%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 9.09%
Nausea (feeling of having an urge to vomit): 2 people, 9.09%
Malignant Melanoma (skin cancer rises from melancytes): 2 people, 9.09%
Dyspnea (difficult or laboured breathing): 2 people, 9.09%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Multaq and Prinivil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously